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ABSTRACT Acute respiratory tract infections (ARI) in infancy have been implicated in the development
of chronic respiratory disease, but the complex interplay between viruses, bacteria and host is not
completely understood. We aimed to prospectively determine whether nasal microbiota changes occur
between the onset of the first symptomatic ARI in the first year of life and 3 weeks later, and to explore
possible associations with the duration of respiratory symptoms, as well as with host, environmental and
viral factors.
Nasal microbiota of 167 infants were determined at both time-points by 16S ribosomal RNA-encoding
gene PCR amplification and subsequent pyrosequencing. Infants were clustered based on their nasal
microbiota using hierarchical clustering methods at both time-points.
We identified five dominant infant clusters with distinct microbiota at the onset of ARI but only three
clusters after 3 weeks. In these three clusters, symptom persistence was overrepresented in the
Streptococcaceae-dominated cluster and underrepresented in the cluster dominated by “Others” (p<0.001).
Duration of symptoms was not associated with the type of respiratory virus.
Infants with prolonged respiratory symptoms after their first ARI tend to exhibit distinct microbial
compositions, indicating close microbiota–host interactions that seem to be of importance for symptom
persistence and recovery.
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RESPIRATORY INFECTIONS
Introduction
Viral infections in infancy and childhood represent a risk factor for the subsequent development of
asthma [1–3]. In addition to viral infections, bacterial colonisation of the airways in neonates with certain
species of bacteria, particularly Moraxella catarrhalis, Haemophilus influenzae and Streptococcus
pneumoniae, has been shown to be associated with the development of childhood asthma [4, 5]. It has
been hypothesised that viral infections may sustainably alter epithelial function, increasing the risk for
chronic airway disease [6], and that changes in microbial diversity may play a role, particularly in
symptomatic infants [7, 8]. It has also been recognised that the airway microbiota in patients with asthma
exhibit distinct differences compared with healthy subjects [9–11]. Bacterial airway colonisation seems to
influence and modulate respiratory morbidity in various conditions such as asthma, cystic fibrosis and
chronic obstructive pulmonary disease [12–14].
Composition of the airway microbiota is highly dynamic and various environmental factors have been
shown to influence colonisation patterns. Antimicrobial exposure and vaccinations, as well as tobacco
smoke exposure, can lead to changes in the airway microbiota [15, 16]. In a prospective cohort study, we
investigated the nasal microbiota in infants longitudinally during the first year of life [17], in the absence
of acute respiratory tract infections (ARI). We showed that the composition of nasal microbiota in infants
is highly dynamic and seems to be predominantly influenced by age and season. However, little is known
about how and to what degree ARIs, which are often caused by viruses, influence the dynamically
changing microbiota. Interactions between viruses and bacteria are well known [18], but their relationship
to respiratory symptoms is not completely understood. Recently, KORTEN et al. [7] demonstrated for
human rhinovirus (HRV) that the microbiota primarily changes in cases of symptomatic ARI, but not in
cases of asymptomatic HRV colonisation. In the study by KORTEN et al. [7], nasal swabs were taken
biweekly throughout the first year of life irrespective of presence or absence of symptoms and not
necessarily at the onset of the very first ARI. BOSCH et al. [19] observed an advanced “microbiota age” in
infants with more frequent ARIs in the first year of life. Thus, we hypothesise that the first symptomatic
viral infection in infection-naïve infants may induce distinct changes in microbiota following commonly
observed respiratory viruses. We also hypothesise that distinct clusters of infants with specific microbial
response patterns can be identified, which could be associated with severity of clinical symptom response
and host risk factors, such as risk for atopy, as suggested by TEO et al. [5].
In a prospective birth cohort of healthy infection-naïve infants, we aimed to: 1) determine whether clusters
based on the upper respiratory tract microbiota changed between the onset of the first symptomatic ARI,
caused by common respiratory viruses, and 3 weeks later; 2) explore the duration of respiratory symptoms,
after the onset of symptoms, in relation to microbiota or virus type; and 3) investigate the association of host
factors, environmental factors and respiratory viruses with infant clusters based on bacterial composition.
Methods
Study design
This study was performed as part of the Basel Bern Infant Lung Development (BILD) cohort study [20].
The study was approved by the local ethics committees (Ethics Committee of the Canton of Bern and
Ethics Committee of Basel (EKBB)). Informed written parental consent was obtained prior to enrolment
in the study. Infants from this prospective birth cohort were followed by weekly standardised telephone
interviews, as previously described [21]. Parents were advised to call the study team as soon as their child
presented with symptoms of an ARI, which was defined as more than two consecutive days of cough and/
or wheeze accompanied by fever (>38°C), rhinitis, otitis media or pharyngitis [20]. Nasal swabs were taken
at the onset of the ARI (swab A) and 3 weeks later (swab B), as described in the supplementary methods.
Nasal swabs were analysed by real-time PCR assays targeting five different respiratory viruses (human
rhinovirus/enterovirus (HRV/EV), respiratory syncytial virus (RSV), human metapneumovirus (HMPV),
human coronavirus (HCoV) and human parainfluenza virus (HPIV)), which have been shown to be the
most common viruses in our population [2]. Details on the methods of viral analysis are provided in the
supplementary methods. The results of viral studies of a subset of infants, also reported in this study, have
been reported previously [2]. Infants were regarded to be at an increased risk for atopy if the infants’
mother, father or siblings were suffering from eczema, allergic rhinitis or allergic asthma. Extensive data
on several host factors were collected using questionnaires [20].
Microbiota analysis
Nasal swabs were prospectively taken at the onset of the first ARI and 3 weeks later. Nasal swabs were
further analysed by amplification of the variable regions V3 to V5 of the bacterial 16S ribosomal RNA
(rRNA) gene by PCR and 454 Titanium FLX sequencing, as described previously [15]. We defined a
cut-off value of 70 reads per sample. The reads from 454 Titanium amplicon sequencing were submitted
to the European Nucleotide Archive (accession number: PRJEB20454). Details of the microbiota analysis,
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the estimation of relative bacterial abundances and the microbiota clustering can be found the
supplementary methods.
Statistical analyses
Descriptive statistics were used to explore and analyse the association between host and environmental
factors and viruses with nasal microbiota. Assuming non-normal distribution, Kruskal–Wallis and
Wilcoxon-signed rank sum tests were used. Fisher’s exact tests, Chi-squared tests and enrichment analyses [22]
were employed where appropriate. Associations between clusters and symptoms were evaluated using
logistic regression analyses and adjusted for season and age. A p-value of <0.05 was considered statistically
significant. Statistical analyses were performed using Stata 11 software (StataCorp. 2009. Stata Statistical
Software: Release 11; StataCorp LP, College Station, TX, USA) and Matlab 2015b (The MathWorks, Inc.,
Natick, MA, USA).
Results
Study population
A total of 252 infants met the criteria for an ARI during the study period. Nasal swabs were available from
200 infants. After exclusion of low-quality samples, nasal swabs of 197 infants were analysed, including
183 complete nasal swab pairs, i.e. available data from the onset of ARI (swab A) and 3 weeks later (swab B).
Prior to final analysis, an additional 16 study participants were excluded due to antibiotic exposure within
4 weeks prior to either swabbing, resulting in 167 nasal swab pairs (figure 1). Table 1 summarises the
sociodemographic and clinical characteristics of the study population.
Description of bacterial composition and diversity
The mean±SD number of reads was 1246.6±684.0. There were only seven out of 334 samples with <250
reads. Composition of the microbial communities consisted of the five most abundant families
Infants with ARI and available nasal swab samples
n=200
PCR ampliﬁcation of 16S rRNA genes
454 amplicon sequencing
16S rRNA amplicons
n=394
Infants with ARI
n=252
Excluded due to missing samples
n=52
Incomplete data pairs excluded
n=14
Nasal swab samples excluded due 
to lack of ampliﬁcation or PCR 
concentration <1 ng·µL–1
n=6
Nasal swab samples excluded due 
to <70 sequence reads or due to 
>5% sequence reads identical to 
negative control
n=14
Nasal swab samples excluded due 
to exposure to antibiotics
n=16
High-quality sequence reads n=469 821
from 380 nasal swabs (infants n=197)
Data on microbiota available for both swabs
n=183
Data on microbiota for both swabs after
exclusion of antimicrobial treatment
n=167
FIGURE 1 Flow chart of the study population. ARI: acute respiratory tract infection.
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(Moraxellaceae, Streptococcaceae, Corynebacteriaceae, Pasteurellaceae and Staphylococcaceae); the
remaining families were grouped together as “Others” (table 2). Among “Others”, the most prevalent
families included Neisseriaceae, Prevotellaceae, Acidaminococcaceae and Flavobacteriaceae. Median
(interquartile range (IQR)) bacterial density was not significantly different between swabs at both
time-points (swab A: 41.5 (37.8) versus swab B: 32.4 (43.1) ng·µL−1). Bacterial abundances of
Corynebacteriaceae and “Others” at the onset of ARI were significantly lower than 3 weeks later (median
(IQR) swab A: 0.1% (0.7) versus swab B: 0.2% (1.1), p=0.002 and median (IQR) swab A: 6.6% (14.7) versus
swab B: 9.4% (27.3), p=0.004, respectively) (table 2). Shannon Diversity Index (SDI) and bacterial richness
of all samples were lower at the onset of ARI compared to 3 weeks later (median (IQR) SDI 1.0 (0.8)
versus 1.1 (1.2), p=0.013; median (IQR) bacterial richness 33 (35) versus 38 (36), p=0.052) (table 2).
TABLE 1 Baseline characteristics of the study population
Total participants n (% male) 167 (57)
Mean±SD gestational age weeks 39.3±2.0
Mean±SD birth weight kg 3.3±0.55
Caesarean section 25 (15)
Season of birth
Spring 62 (37)
Summer 44 (26)
Autumn 32 (19)
Winter 29 (17)
Mean±SD (range) age at ARI weeks 29.9±12.5 (2–52)
Season at first ARI
Spring 40 (24)
Summer 14 (8)
Autumn 38 (23)
Winter 75 (45)
Increased atopy risk 109 (65)
Childcare attendance 32 (19)
Breastfeeding status at time of ARI# 99 (60)
Environmental tobacco smoke exposure 24 (14)
Other siblings (living in the same household) 106 (63)
One sibling 75 (45)
⩾2 siblings 31 (19)
Data are presented as n (%), unless otherwise stated. ARI: acute respiratory tract infection. #: infants
being breastfed at the time of ARI.
TABLE 2 Abundances of bacterial families and alpha diversity measurements at the onset of
the acute respiratory tract infection (ARI) and 3 weeks after the onset
At ARI onset (swab A) 3 weeks after ARI onset (swab B)
Bacterial family abundance %
Moraxellaceae 52.4 (66.5) 49.5 (66.2)
Streptococcaceae 19.2 (41.03) 16.31 (33.9)
Corynebacteriaceae 0.1 (0.7) 0.2 (1.1)#
Pasteurellaceae 0.4 (1.9) 0.3 (1.5)
Staphylococcaceae 0.1 (0.6) 0.1 (0.6)
“Others” 6.6 (14.7) 9.4 (27.3)#
Alpha diversity measurements
SDI 1.0 (0.8) 1.1 (1.2)¶
Bacterial richness 33 (35) 38 (36)¶
Data are presented as median (interquartile range). SDI: Shannon Diversity Index. #: abundance of
Corynebacteriaceae and “Others” were significantly different between swab A and swab B (p=0.002 and
0.004, respectively, Wilcoxon signed rank sum test); ¶: SDI and bacterial richness are lower at swab A
compared to swab B (p=0.013 and 0.052, respectively, Wilcoxon signed rank sum test).
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Infant cluster analysis based on bacterial families
Five main clusters could be identified in swab A (n=165), whereas only three main clusters could be
identified in swab B (n=155) (figure 2). The five most prevalent clusters at swab A were cluster A1
(Moraxellaceae-dominated, 33.9%), cluster A2 (Moraxellaceae and Streptococcaceae-dominated, 30.9%),
cluster A3 (Streptococcaceae-dominated, 18.8%), cluster A4 (“Others”-dominated, 8.5%) and cluster A5
(Pasteurellaceae-dominated, 7.9%). The three clusters based on bacterial abundances at swab B were cluster
B1 (Moraxellaceae-dominated, 61.9%), cluster B2 (“Others”-dominated, 21.9%) and cluster B3
(Streptococcaceae-dominated, 16.1%) (figure 2). The most abundant cluster in both swabs was dominated
by Moraxellaceae, which showed the lowest bacterial diversity (median (IQR) SDI A1: 0.67 (0.63); B1: 0.88
(0.76)). The number of infants in this cluster increased between swab A and B from 33.9% to 61.9%
(figure 3). Bacterial diversity was highest in clusters A4 and B2 (median (IQR) SDI A4: 2.54 (1.52); B2:
2.40 (0.56)). Differences in the SDI and Jaccard dissimilarity indices between infant clusters were
significant (p<0.001) (table S1).
Influence of host and environmental factors on infant clusters
Associations with the following factors were explored: age, season at first ARI, sex, cohabitating siblings,
caesarean section, atopy, childcare attendance, breastfeeding status and environmental tobacco smoke
exposure (tables S2 and S3). Statistically significant differences between clusters at the onset of infection
could be seen in infants with risk for atopy, with higher proportions in cluster A2 and A5 (76.5% and
84.6%, respectively) compared to cluster A3 (38.7%) (p=0.008). In swab B, childcare attendance was
overrepresented in the Moraxellaceae-dominated cluster B1 (p=0.030).
Results of viral analysis
Real-time PCR detected viruses in 108 (64.7%) infants. The most abundant viruses in swab A were RSV
(17.8%), followed by HRV/EV (13.8%), HPIV (11.4%), HMPV (6.0%) and HCoV (5.4%). 3 weeks after the
onset of ARI (swab B) the number of detected viruses was lower (except for HCoV), the most frequently
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FIGURE 2 Composition of the most common clusters at the a) onset of the first acute respiratory tract
infection (swab A) and b) 3 weeks later (swab B) illustrated as bacterial abundances of the five most common
bacterial families with the remaining grouped as “Others”. Clusters with sizes of <5% are not depicted.
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detected viruses were RSV (11.4%), followed by HRV/EV (10.8%), HCoV (6.0%), HPIV (3.0%) and
HMPV (3.0%). In 59 (35.3%) subjects none of the targeted viruses could be detected. At the onset of
infection, only HMPV occurrence was significantly different between the clusters, with the highest
detection rate in cluster A3 (16.1%) (p=0.030) (table S4). 3 weeks later, HRV/EV was overrepresented in
the Moraxellaceae-dominated cluster B1 (14.6%) versus B2 (2.9%) and B3 (0.0%) (p=0.030); HCoV was
overrepresented in cluster B3 (20.0%) versus B1 (4.2%) and B2 (0.0%) (p=0.007). HRV and HCoV were
both underrepresented in the “Others”-dominated cluster B2 (p=0.020 and p<0.001, respectively) (table S5).
Duration of respiratory symptoms and infant clusters
Symptom persistence after the onset of infection showed a mean±SD (range, median) duration of 2.3±1.5
(1–11, 2) weeks. Presence of symptoms 2 weeks after the onset of ARI showed a borderline significant
difference between clusters determined at swab A (p=0.061): symptomatic infants were more common in
cluster A2 (37.3%, p=0.025) and underrepresented in clusters A3 (12.9%, p<0.01) and A4 (7.1%, p<0.01)
(table 3).
Presence of symptoms 3 weeks after the onset of ARI was different between clusters in swab B (p<0.001).
There were less symptomatic infants in cluster B2 (5.9%, odds ratio (95% CI) 0.2 (0.0–0.7)) and more
symptomatic infants in clusters B1 (29.2%) and B3 (56.0%, odds ratio (95% CI) 3.3 (1.3–8.0)) (figure 3,
table 4 and table S6). Adjusting for host and environmental factors did not change these associations
(table S7). Interestingly, SDI in swab B was much higher in cluster B2 (median (IQR) SDI: 2.40 (0.56))
compared to B1 (0.88 (0.76)) and B3 (1.06 (0.69)) (p<0.001; table S1).
Overall, in clusters with lower diversity and overrepresentation of Moraxellaceae or Streptococcaceae (A1,
B1 and B3) the proportion of persistently symptomatic patients was higher, whereas infants in clusters
characterised by high diversity and overrepresentation of “Others” (A4 and B2), showed more rapid
symptom recovery following ARI (figure 3 and table 4).
The type of virus at swab A and swab B was not associated with the duration of respiratory symptoms
(tables S8–S10).
B1
(SDI=0.88)
B2
(SDI=2.40)
B3
(SDI=1.06)
A1
(SDI=0.67)
A2
(SDI=1.18)
A3
(SDI=1.02)
A4
(SDI=2.54)
A5
(SDI=0.87)
56
51
31
14
13
96
34
25
FIGURE 3 Results of hierarchical clustering based on the microbial composition at the onset of the first acute
respiratory tract infection (swab A) and 3 weeks later (swab B). The size of the circles and the numbers inside
indicate the number of individuals assigned to each cluster. The connecting bars indicate the transition from one
particular cluster to another between swabs A and B; the size of the bars corresponds to the number of
transitioning individuals. The dominating bacterial families in the clusters are as follows. A1: Moraxellaceae;
A2: Moraxellaceae and Streptococcaeae; A3: Streptococcaceae; A4: “Others”; A5: Pasteurellaceae; B1:
Moraxellaceae; B2: “Others”; B3: Streptococcaceae. Areas in the circles of darker green on the left side of the
panel indicate the proportion of infants at swab A in each cluster who were asymptomatic at swab B compared to
the proportion of symptomatic infants at swab B (lighter green). Areas in the circles of darker orange on the
right side of the panel indicate the proportion of asymptomatic infants at swab B compared to the proportion of
symptomatic infants (lighter orange). SDI: Shannon Diversity Index, presented as the median value.
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Discussion
Using an unsupervised approach in a representative, prospective, central European white healthy birth
cohort [20], we could show that the nasal microbiota of infection-naïve infants exhibited five distinct
major microbial patterns at the onset of the first ARI, largely independent of the type of common
respiratory virus. 3 weeks after the onset of the ARI, these five distinct clusters became three dominant
clusters. The duration of respiratory symptoms was associated with clusters based on microbiota 3 weeks
after the onset of infection, but not with commonly observed respiratory viruses, indicating close
microbiota–host interactions.
Bacterial composition of nasal swabs in our study consisted primarily of five families (Moraxellaceae,
Streptococcaceae, Corynebacteriaceae, Pasteurellaceae and Staphylococcaceae), which is comparable to
previous studies on microbiota in infants and young children [5, 7, 15, 17, 23]. In contrast to a previous
study from our group [7], where nasal swabs were taken biweekly throughout the first year of life
irrespective of presence or absence of respiratory symptoms, in this study we focused specifically on the
nasal microbiota at the very first ARI and 3 weeks later.
We observed less symptomatic infants in the “Others”-dominated cluster B2 3 weeks after the onset of
infection. Bacterial abundances of Staphylococcaceae and Corynebacteriaceae were significantly higher in
cluster B2 than in clusters B1 or B3 (figure 2). Similarly, TEO et al. [5] recognised Staphylococcus and
Corynebacterium as commensals, which seem to be associated with respiratory health. BOSCH et al. [19]
observed an underrepresentation of Dolosigranulum and Corynebacterium and an overrepresentation of
Moraxellaceae in infants with more frequent ARI in their first year of life. 3 weeks after the onset of ARI,
we found most symptomatic infants in the Streptococcaceae-dominated cluster B3.
HRV/EV detection was higher in the Moraxellaceae-dominated cluster B1. This is consistent with
published observations. KORTEN et al. [7] reported a higher abundance of Moraxellaceae in infants with
symptomatic HRV/EV infections. KLOEPFER et al. [24] found similarly increased detection rates of
M. catarrhalis and S. pneumoniae associated with HRV/EV. BOSCH et al. [19] found the more frequent ARI
in infants with a premature predominance of Moraxellaceae.
TABLE 4 Infant clusters 3 weeks after onset of acute respiratory tract infection (ARI) (swab B)
and subsequent presence of symptoms after the onset of the first ARI
Cluster (n=155) B1 (n=96) B2 (n=34) B3 (n=25) p-value
Symptomatic after 1 week 70 (72.9) 22 (64.7) 16 (64.0) 0.135#
Symptomatic after 2 weeks 28 (30.2) 5 (14.7) ↓ 9 (36.0) 0.454#
Symptomatic after 3 weeks 27 (29.2) 2 (5.9) ↓ 14 (56.0) ↑ <0.001¶
Continuously symptomatic for ⩾3 weeks 16 (16.7) 1 (2.9) ↓ 9 (36.0) ↑ 0.010¶
Data are presented as n (%), unless otherwise stated. Statistical analyses were performed using #:
Chi-squared; or ¶: Fisher’s exact test. Significant overrepresentation (↑) and significant
underrepresentation (↓) of presence of symptoms in the clusters was assessed by enrichment analysis.
The dominating bacterial families in the clusters are as follows. B1: Moraxellaceae; B2: “Others”; B3:
Streptococcaceae.
TABLE 3 Infant clusters at the onset of acute respiratory tract infection (swab A) and subsequent presence of symptoms
Cluster (n=165) p-value
A1
(n=56)
A2
(n=51)
A3
(n=31)
A4
(n=14)
A5
(n=13)
Symptomatic after 1 week 38 (67.8) 43 (84.3) ↑ 19 (61.3) 8 (53.3) 9 (69.2) 0.121#
Symptomatic after 2 weeks 17 (30.4) 19 (37.3) ↑ 4 (12.9) ↓ 1 (7.1) ↓ 4 (30.8) 0.061¶
Symptomatic after 3 weeks 19 (33.9) 12 (23.5) 8 (25.8) 4 (28.6) 5 (38.5) 0.754¶
Continuously symptomatic for ⩾3 weeks 13 (23.3) 9 (17.6) 2 (6.5) ↓ 1 (7.1) 3 (23.1) 0.329¶
Data are presented as n (%), unless otherwise stated. Statistical analyses were performed using #: Chi-squared; or ¶: Fisher’s exact test.
Significant overrepresentation (↑) and significant underrepresentation (↓) of presence of symptoms in the clusters was assessed by enrichment
analysis. The dominating bacterial families in the clusters are as follows. A1: Moraxellaceae; A2: Moraxellaceae and Streptococcaeae; A3:
Streptococcaceae; A4: “Others”; A5: Pasteurellaceae.
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The strength of the study is the relatively high number of infants studied from a prospective birth cohort
with comprehensive information on antenatal and postnatal history, including weekly telephone interviews
to monitor respiratory symptoms [20]. However, due to the high variability of the microbiota, it is possible
that significant differences in the bacterial composition associated with certain viruses and host factors
could only become obvious with an even larger study sample. A limitation of our study is that the age at
onset of ARI naturally varied, since the focus of this prospective study was to study the very first
symptomatic ARI in infants. Our study design precludes information on the nasal microbiota in an
asymptomatic period immediately prior to the first ARI. Additional information on this could help
identify changes in the bacterial composition which might have preceded symptoms of the ARI.
Viral–bacterial interactions are complex and certain combinations of viruses and bacteria can exert either
synergistic or inhibitory effects. It seems that certain bacteria can lead to an enhanced or reduced
inflammatory response, and thereby modulate the burden of respiratory symptoms [8]. In clusters of infants
with persistent symptoms 3 weeks after the onset of infection the microbiota was dominated by
Moraxellaceae and Streptococcaceae. A higher abundance of these two potentially pathogenic bacterial
families might result in an ARI with sustained symptoms. This is in accordance with a recent study of
young children showing an exaggerated inflammatory response to RSV in the presence of nasopharyngeal
microbiota enriched with H. influenzae and S. pneumoniae [8]. In contrast, in cluster B2, in which infants
had fewer symptoms, the microbiota contained higher abundances of Corynebacteriaceae and
Staphylococcaceae. These organisms have similarly been identified by TEO et al. [5] to be associated with
respiratory health [19]. Nasopharyngeal Staphylococcus aureus was found to be associated with lower
disease severity in RSV infections [8]. BIESBROEK et al. [23] and BOSCH et al. [19] reported less ARI in infants
with nasopharyngeal microbiota dominated by Corynebacterium and Dolosigranulum. Whether these
organisms are simply biomarkers indicating respiratory health, or whether they have immediate protective
effects on the respiratory tract, remains unclear. Cluster B2 was also characterised by higher bacterial
diversity compared to the other clusters. Lower diversity in infants with longer persistence of symptoms
could reflect an outgrowth of certain potentially pathogenic bacterial families, e.g. Moraxellaceae, or
potentially a lack of beneficial microbiota. It has been shown that the production of pro-inflammatory
cytokines by dendritic cells is higher after stimulation by M. catarrhalis and H. influenzae compared to
Prevotella strains, common commensals of the respiratory tract microbiota. Co-stimulation with Prevotella
reduces the H. influenzae-induced production of pro-inflammatory cytokines [25]. This could indicate that
commensals, such as Prevotella and others, are not only filling a niche, but are also functionally important
for the maintenance of “healthy” equilibrium. In a recent study, we observed that a lower bacterial diversity
was associated with more frequent HRV infections in the first year of life [26].
Manipulation of airway microbiota with, for example, probiotics seems attractive, but a prerequisite would
be to know the “ideal” microbial composition associated with respiratory health and the highest resilience.
In conclusion, infants with prolonged respiratory symptoms after their very first ARI exhibit distinct nasal
microbiota compared to infants with faster recovery, indicating the presence of close microbiota–host
interactions. Future studies will need to reveal how the microbial composition influences the dynamic
equilibrium of viruses and bacteria, and how this is related to inflammation, mucosal function, immune
development and subsequent chronic lung disease.
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